Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder

the effects of antipsychotic treatment

Rajiv P. Sharma, Garth Bissette, Philip Janicak, John M. Davis, Charles Nemeroff

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The authors examined the effects of antipsychotic treatment on cerebrospinal fluid somatostatin like immunoreactivity (CSF SLI) in 14 schizophrenic and 3 schizoaffective patients. There was a modest but significant increase in CSF SLI in 13 out of the 14 schizophrenic patients. In addition, there was a significant positive correlation between duration of treatment and post-treatment CSF SLI concentrations. No differential response was noted in patients also treated with the anticholinergic benztropine.

Original languageEnglish
Pages (from-to)173-177
Number of pages5
JournalSchizophrenia Research
Volume13
Issue number2
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Somatostatin
Psychotic Disorders
Antipsychotic Agents
Cerebrospinal Fluid
Schizophrenia
Benztropine
Cholinergic Antagonists
Therapeutics
somatostatin-like peptides

Keywords

  • Antipsychotic
  • Homovanillic acid
  • Somatostatin

ASJC Scopus subject areas

  • Psychology(all)
  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology

Cite this

Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder : the effects of antipsychotic treatment. / Sharma, Rajiv P.; Bissette, Garth; Janicak, Philip; Davis, John M.; Nemeroff, Charles.

In: Schizophrenia Research, Vol. 13, No. 2, 01.01.1994, p. 173-177.

Research output: Contribution to journalArticle

@article{f745ac1dd3874f758168d1f73fb2c087,
title = "Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment",
abstract = "The authors examined the effects of antipsychotic treatment on cerebrospinal fluid somatostatin like immunoreactivity (CSF SLI) in 14 schizophrenic and 3 schizoaffective patients. There was a modest but significant increase in CSF SLI in 13 out of the 14 schizophrenic patients. In addition, there was a significant positive correlation between duration of treatment and post-treatment CSF SLI concentrations. No differential response was noted in patients also treated with the anticholinergic benztropine.",
keywords = "Antipsychotic, Homovanillic acid, Somatostatin",
author = "Sharma, {Rajiv P.} and Garth Bissette and Philip Janicak and Davis, {John M.} and Charles Nemeroff",
year = "1994",
month = "1",
day = "1",
doi = "10.1016/0920-9964(94)90099-X",
language = "English",
volume = "13",
pages = "173--177",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder

T2 - the effects of antipsychotic treatment

AU - Sharma, Rajiv P.

AU - Bissette, Garth

AU - Janicak, Philip

AU - Davis, John M.

AU - Nemeroff, Charles

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The authors examined the effects of antipsychotic treatment on cerebrospinal fluid somatostatin like immunoreactivity (CSF SLI) in 14 schizophrenic and 3 schizoaffective patients. There was a modest but significant increase in CSF SLI in 13 out of the 14 schizophrenic patients. In addition, there was a significant positive correlation between duration of treatment and post-treatment CSF SLI concentrations. No differential response was noted in patients also treated with the anticholinergic benztropine.

AB - The authors examined the effects of antipsychotic treatment on cerebrospinal fluid somatostatin like immunoreactivity (CSF SLI) in 14 schizophrenic and 3 schizoaffective patients. There was a modest but significant increase in CSF SLI in 13 out of the 14 schizophrenic patients. In addition, there was a significant positive correlation between duration of treatment and post-treatment CSF SLI concentrations. No differential response was noted in patients also treated with the anticholinergic benztropine.

KW - Antipsychotic

KW - Homovanillic acid

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0028021031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028021031&partnerID=8YFLogxK

U2 - 10.1016/0920-9964(94)90099-X

DO - 10.1016/0920-9964(94)90099-X

M3 - Article

VL - 13

SP - 173

EP - 177

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 2

ER -